RxDoctor Payments DataLook up a doctor →

Fulphila: payments to doctors

Payments that named Fulphila as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$81K
Providers
1,038
Transactions
1,589
Average per transaction
$51

The per-transaction average — $51 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,038 providers the average total is $78, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Mylan Institutional Inc.$57,97371.2%
Mylan Inc.$15,81419.4%
Biocon Biologics Inc$7,5019.2%
Mylan Pharmaceuticals Inc.$900.1%
← All drugs & devices